# US 2026/0083739 A1 · Dietary macro/micronutritional compositions and applications thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083739 A1
- Document ID: US20260083739A1
- Status: Published application
- Kind: A1
- Application number: 19/405,496
- Filed: 2025-12-02
- Published: 2026-03-26
- Earliest claimed: 2022-05-05
- Inventors: Atif DABDOUB
- Web page: https://patentgrep.com/patent/US20260083739A1

## CPC

- A61K 31/51: Thiamines, e.g. vitamin B1
- A23L 33/15: Vitamins
- A23L 33/16: Inorganic salts, minerals or trace elements
- A23L 33/175: Amino acids
- A61K 31/122: having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K 31/197: the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid (carnitine A61K31/205)
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 31/20: having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K 31/201: having one or two double bonds, e.g. oleic, linoleic acids
- A61K 31/205: Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A61K 31/375: Ascorbic acid, i.e. vitamin C; Salts thereof
- A61K 31/381: having five-membered rings
- A61K 31/4188: condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
- A61K 31/4415: Pyridoxine, i.e. Vitamin B6 (pyridoxal phosphate A61K31/675)
- A61K 31/455: Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61K 31/525: Isoalloxazines, e.g. riboflavins, vitamin B2
- A61K 31/593: 9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
- A61K 31/714: Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A61K 31/732: Pectin
- A61K 33/04: Sulfur, selenium or tellurium; Compounds thereof
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 33/22: Boron compounds
- A61K 33/24: Heavy metals; Compounds thereof
- A61K 33/26: Iron; Compounds thereof
- A61K 33/30: Zinc; Compounds thereof
- A61K 33/32: Manganese; Compounds thereof
- A61K 33/34: Copper; Compounds thereof
- A61K 36/21: Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
- A61K 38/063: {Glutathione}
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K 47/46: Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 39/06: Free radical scavengers or antioxidants
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Provided herein are compositions composed of a plurality of minerals and vitamins that provide numerous health benefits and quality of life to subjects in need thereof. Also described herein are kits composed of the compositions described herein with a marine omega 3 fatty acid, coenzyme Q10, or a combination thereof. In one aspect, the compositions described herein can treat a subject diagnosed with prediabetes, type 1 diabetes, type 2 diabetes or insulin uptake. In another aspect, the compositions described herein can increase the performance of athletes by relaxing and dilating blood vessels, thus improve circulation as well as shorten the time of recovery after exercises or games. In another aspect, the compositions described herein can improve the well-being and immune response system. It also improves the human system against bacterial and fungal infections. In another aspect, the compositions described herein can treat myalgic encephalomyelitis in a subject. In another aspect, the compositions described herein can reduce or prevent one or more symptoms of Crohn's disease in a subject. In another aspect, the compositions described herein can enhance one or more physical properties of a subject after exercise.

## Claims

### Claim 1

A composition comprising
vitamin B1
vitamin B2
vitamin B3
vitamin B5
vitamin B6
vitamin B7
vitamin B9
vitamin B12
vitamin C
vitamin D3
a pharmaceutically-acceptable compound of calcium
a pharmaceutically-acceptable compound of magnesium
a pharmaceutically-acceptable compound of zinc
a pharmaceutically-acceptable compound of selenium
a pharmaceutically-acceptable compound of iron
a pharmaceutically-acceptable compound of L-carnitine
a pharmaceutically-acceptable compound of L-arginine
a pharmaceutically-acceptable compound of L-citrulline
red beetroot extract
a pharmaceutically-acceptable compound of boron
glutathione or pharmaceutically-acceptable salt thereof
sugar beet pectin pectin
alpha lipoic acid.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the composition comprises
vitamin B1 in an amount of from about 0.010 weight percent to about 0.050 weight percent of the composition;
vitamin B2 in an amount of from about 0.010 weight percent to about 0.050 weight percent of the composition;
vitamin B3 in an amount of from about 0.10 weight percent to about 0.50 weight percent of the composition;
vitamin B5 in an amount of from about 0.01 weight percent to about 0.50 weight percent of the composition;
vitamin B6 in an amount of from about 0.01 weight percent to about 0.50 weight percent of the composition;
vitamin B7 in an amount of from about 0.05 weight percent to about 1.00 weight percent of the composition;
vitamin B9 in an amount of from about 0.001 weight percent to about 0.10 weight percent of the composition;
vitamin B12 in an amount of from about 0.05 weight percent to about 2.00 weight percent of the composition;
vitamin C in an amount of from about 1.00 weight percent to about 5.00 weight percent of the composition;
vitamin D3 in an amount of from about 0.01 weight percent to about 0.50 weight percent of the composition;
a pharmaceutically-acceptable compound of calcium in an amount of from about 10.00 weight percent to about 35.00 weight percent of the composition;
a pharmaceutically-acceptable compound of magnesium in an amount of from about 15.00 weight percent to about 40.00 weight percent of the composition;
a pharmaceutically-acceptable compound of zinc in an amount of from about 0.10 weight percent to about 2.00 weight percent of the composition;
a pharmaceutically-acceptable compound of selenium in an amount of from about 0.10 weight percent to about 1.50 weight percent of the composition;
a pharmaceutically-acceptable compound of iron in an amount of from about 0.50 weight percent to about 5.00 weight percent of the composition;
a pharmaceutically-acceptable compound of L-carnitine in an amount of from about 10.00 weight percent to about 30.00 weight percent of the composition;
glutathione or pharmaceutically-acceptable salt thereof in an amount of from about 0.50 weight percent to about 5.00 weight percent of the composition
a pharmaceutically-acceptable compound of L-arginine in an amount of from about 1.00 weight percent to about 10.00 weight percent of the composition;
a pharmaceutically-acceptable compound of L-citrulline in an amount of from about 1.00 weight percent to about 10.00 weight percent of the composition;
a pharmaceutically-acceptable compound of boron in an amount of from about 0.001 weight percent to about 0.20 weight percent of the composition;
red beetroot extract in an amount of from about 1.00 weight percent to about 15.00 weight percent of the composition;
sugar beet pectin in an amount of from about 0.50 weight percent to about 5.00 weight percent of the composition; and
alpha lipoic acid in an amount of from about 1.00 weight percent to about 10.00 weight percent of the composition.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the composition is unit dose composition comprising
vitamin B1 in an amount of from about 0.10 weight percent to about 0.03 weight percent of the composition;
vitamin B2 in an amount of from about 0.10 weight percent to about 0.30 weight percent of the composition;
vitamin B3 in an amount of from about 0.20 weight percent to about 0.30 weight percent of the composition;
vitamin B5 in an amount of from about 0.0.05 weight percent to about 0.30 weight percent of the composition;
vitamin B6 in an amount of from about 0.01 weight percent to about 1.50 weight percent of the composition;
vitamin B7 in an amount of from about 0.05 weight percent to about 0.30 weight percent of the composition;
vitamin B9 in an amount of from about 0.001 weight percent to about 0.02 weight percent of the composition;
vitamin B12 in an amount of from about 0.05 weight percent to about 0.50 weight percent of the composition;
vitamin C in an amount of from about 1.00 weight percent to about 5.00 weight percent of the composition;
vitamin D3 in an amount of from about 0.10 weight percent to about 1.00 weight percent of the composition;
a pharmaceutically-acceptable compound of calcium in an amount of from about 15.00 weight percent to about 25.00 weight percent of the composition;
a pharmaceutically-acceptable compound of magnesium in an amount of from about 15.00 weight percent to about 25.00 weight percent of the composition;
a pharmaceutically-acceptable compound of zinc in an amount of from about 0.50 weight percent to about 1.50 weight percent of the composition;
a pharmaceutically-acceptable compound of selenium in an amount of from about 0.10 weight percent to about 2.00 weight percent of the composition;
a pharmaceutically-acceptable compound of iron in an amount of from about 1.00 weight percent to about 5.00 weight percent of the composition;
a pharmaceutically-acceptable compound of L-carnitine in an amount of from about 15.00 weight percent to about 25.00 weight percent of the composition;
glutathione or pharmaceutically-acceptable salt thereof in an amount of from about 1.00 weight percent to about 4.00 weight percent of the composition.
a pharmaceutically-acceptable compound of L-arginine in an amount of from about 3.00 weight percent to about 8.00 weight percent of the composition;
a pharmaceutically-acceptable compound of L-citrulline in an amount of from about 3.00 weight percent to about 8.00 weight percent of the composition;
a pharmaceutically-acceptable compound of boron in an amount of from about 0.010 weight percent to about 0.015 weight percent of the composition;
red beetroot extract in an amount of from about 5.00 weight percent to about 7.00 weight percent of the composition;
sugar beet pectin in an amount of from about 2.00 weight percent to about 3.00 weight percent of the composition; and
alpha lipoic acid in an amount of from about 3.00 weight percent to about 4.00 weight percent of the composition.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the composition further comprises a pharmaceutically-acceptable compound of chromium.

### Claim 5 (depends on 4)

The composition of claim 4, wherein the pharmaceutically-acceptable compound of chromium in an amount of from about 0.001 weight percent to about 0.010 weight percent of the composition.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the composition further comprises a citrus bioflavonoid, a powdered extract of cranberry and/or cherry, or a combination thereof.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the composition comprises a dry powder.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the composition further comprises a polysaccharide filler.

### Claim 9 (depends on 8)

The composition of claim 8, wherein the polysaccharide filler comprises maltodextrin.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the composition does not include a pharmaceutically-acceptable compound of potassium, sodium, or phosphorous.

### Claim 11 (depends on 1)

A kit comprising
the composition of claim 1; and
a marine omega 3 fatty acid, coenzyme Q10, or a combination thereof.

### Claim 12 (depends on 11)

The kit of claim 11, wherein the marine omega 3 fatty acids comprise DHA and EPA in the weight ratio (EPA:DHA) of 1:1 to 4:1.

### Claim 13 (depends on 11)

The kit of claim 11, wherein the marine omega 3 fatty acids are in the amount of 500 mg to 4,000 mg per unit dose.

### Claim 14 (depends on 11)

The kit of claim 11, wherein coenzyme Q10 is ubiquinol.

### Claim 15 (depends on 11)

The kit of claim 11, wherein the coenzyme Q10 is in the amount of 70 mg to 400 mg per unit dose.

### Claim 16 (depends on 11)

The kit of claim 11, wherein the kit optionally comprises a capsule comprising turmeric, wherein the turmeric is in the amount of 1 g to 3 g per unit dose.

### Claim 17 (depends on 11)

A method for enhancing one or more physical properties of a subject after exercise comprising administering to the subject a therapeutically effective amount of the composition of claim 11 before and/or after exercise.

### Claim 18 (depends on 17)

The method of claim 17, wherein the physical property comprises improved or faster recovery after exercise, increased energy, increased body strength, improved appetite, improved sleep, reduced muscle and joint pain or soreness, improved lactic acid dissipation, improved endurance, reduced cramping, improved well-being, or any combination thereof.
